ORCID as entered in ROS
https://orcid.org/0000-0002-4560-0259
Select Publications
Journal articles
, 2004, 'High-Level Expression of Dok-1 in Neurons of the Primate Prefrontal Cortex and Hippocampus', Journal of Neuroscience Research, 75, pp. 218 - 224, http://dx.doi.org/10.1002/jnr.10842
, 2004, 'Glutamate Carboxypeptidase II Gene Expression in the Human Frontal and Temporal Lobe in Schizophrenia', Neuropsychopharmacology, 29, pp. 117 - 125, http://dx.doi.org/10.1038/sj.npp.1300304
, 2004, 'Reduced spinophilin but not microtubule-associated protein 2 expression in the hippocampal formation in schizophrenia and mood disorders: Molecular evidence for a pathology of dendritic spines', American Journal of Psychiatry, 161, pp. 1848 - 1855, http://dx.doi.org/10.1176/ajp.161.10.1848
, 2004, 'Reduced GSK-alpha mRNA levels in postmortem dorsolateral prefrontal cortex of schizophrenic patients.', Journal of Neural Transmission, 111, pp. 1583 - 1592, http://dx.doi.org/10.1007/s00702-004-0166-3
, 2003, 'Presynaptic proteins in the prefrontal cortex of patients with schizophrenia and rats with abnormal prefrontal development', Molecular Psychiatry, 8, pp. 797 - 810, http://dx.doi.org/10.1038/sj.mp.4001319
, 2003, 'Expression of NMDA receptor NR1, NR2A and NR2B subunit mRNAs during development of the human hippocampal formation', European Journal of Neuroscience, 18, pp. 1197 - 1205, http://dx.doi.org/10.1046/j.1460-9568.2003.02850.x
, 2003, 'Reduced brain-derived neurotrophic factor in prefrontal cortex of patients with schizophrenia', Molecular Psychiatry, 8, pp. 592 - 610, http://dx.doi.org/10.1038/sj.mp.4001308
, 2003, 'Catechol O-methyltransferase (COMT) mRNA expression in the dorsolateral prefrontal cortex of patients with schizophrenia', Neuropsychopharmacology, 28, pp. 1521 - 1530, http://dx.doi.org/10.1038/sj.npp.1300218
, 2003, 'Catechol O-methyltransferase mRNA expression in human and rat brain: Evidence for a role in cortical neuronal function', Neuroscience, 116, pp. 127 - 137, http://dx.doi.org/10.1016/S0306-4522(02)00556-0
, 2003, 'Epidermal growth factor receptor expression is related to post-mitotic events in cerebellar development: Regulation by thyroid hormone', Developmental Brain Research, 140, pp. 1 - 13, http://dx.doi.org/10.1016/S0165-3806(02)00539-4
, 2003, 'Changes in NMDA Receptor Subunit mRNAs and Cyclophilin mRNA during Development of the Human Hippocampus', Annals of the New York Academy of Sciences, 1003, pp. 426 - 430, http://dx.doi.org/10.1196/annals.1300.043
, 2003, 'Gene expression in dopamine and GABA systems in an animal model of schizophrenia: Effects of antipsychotic drugs', European Journal of Neuroscience, 18, pp. 391 - 402, http://dx.doi.org/10.1046/j.1460-9568.2003.02738.x
, 2002, 'Alterations in trkB mRNA in the human prefrontal cortex throughout the lifespan', European Journal of Neuroscience, 15, pp. 269 - 280, http://dx.doi.org/10.1046/j.0953-816x.2001.01858.x
, 2002, 'BDNF mRNA expression during postnatal development, maturation and aging of the human prefrontal cortex', Developmental Brain Research, 139, pp. 139 - 150, http://dx.doi.org/10.1016/S0165-3806(02)00540-0
, 2002, 'Regional specificity of brain glucocorticoid receptor mRNA alterations in subjects with schizophrenia and mood disorders', Molecular Psychiatry, 7, pp. 985 - 994, http://dx.doi.org/10.1038/sj.mp.4001139
, 2001, 'Synaptophysin and GAP-43 mRNA levels in the hippocampus of subjects with schizophrenia', Schizophrenia Research, 49, pp. 89 - 98, http://dx.doi.org/10.1016/S0920-9964(00)00052-9
, 2001, 'Delayed onset of enhanced MK-801-induced motor hyperactivity after neonatal lesions of the rat ventral hippocampus', Biological Psychiatry, 49, pp. 528 - 539, http://dx.doi.org/10.1016/S0006-3223(00)00968-9
, 2001, 'BDNF mRNA expression in rat hippocampus and prefrontal cortex: Effects of neonatal ventral hippocampal damage and antipsychotic drugs', European Journal of Neuroscience, 14, pp. 135 - 144, http://dx.doi.org/10.1046/j.1460-9568.2001.01633.x
, 2001, 'Reduced GAP-43 mRNA in dorsolateral prefrontal cortex of patients with schizophrenia', Cerebral Cortex, 11, pp. 136 - 147, http://dx.doi.org/10.1093/cercor/11.2.136
, 2000, 'Differential DNA damage in response to the neonatal and adult excitotoxic hippocampal lesion in rats', European Journal of Neuroscience, 12, pp. 4424 - 4433, http://dx.doi.org/10.1046/j.0953-816X.2000.01320.x
, 2000, 'Localization of epidermal growth factor receptors and putative neuoblasts in human subependymal zone', Journal of Comparative Neurology, 423, pp. 359 - 372, http://dx.doi.org/10.1002/1096-9861(20000731)423:3<359::AID-CNE1>3.0.CO;2-0
, 1999, 'The weaver GIRK2 mutation leads to decreased levels of serum thyroid hormone: Characterization of the effect on midbrain dopaminergic neuron survival', Experimental Neurology, 160, pp. 413 - 424, http://dx.doi.org/10.1006/exnr.1999.7231
, 1998, 'A candidate molecule approach to defining developmental pathology in schizophrenia', Schizophrenia Bulletin, 24, pp. 303 - 316, http://dx.doi.org/10.1093/oxfordjournals.schbul.a033327
, 1998, 'The neuroanatomy and neurochemistry of schizophrenia', Psychiatric Clinics of North America, 21, pp. 57 - 75, http://dx.doi.org/10.1016/S0193-953X(05)70361-0
, 1997, 'Neuropathology of suicide. A review and an approach', Annals of the New York Academy of Sciences, 836, pp. 201 - 219, http://dx.doi.org/10.1111/j.1749-6632.1997.tb52361.x
, 1995, 'Striatal TGF-α: postnatal developmental expression and evidence for a role in the proliferation of subependymal cells', Developmental Brain Research, 86, pp. 203 - 216, http://dx.doi.org/10.1016/0165-3806(95)00026-A
, 1995, 'GDNF mRNA expression in normal postnatal development, aging, and in weaver mutant mice', Neurobiology of Aging, 16, pp. 925 - 929, http://dx.doi.org/10.1016/0197-4580(95)02011-X
, 1995, 'Glutamate regulation of GDNF gene expression in the striatum and primary striatal astrocytes', NeuroReport, 6, pp. 1454 - 1458, http://dx.doi.org/10.1097/00001756-199507100-00023
Conference Papers
, 2021, 'Stratifying by Inflammatory Status Reveals Novel Neuropathology in Neurogenic Niche in Schizophrenia', in NEUROPSYCHOPHARMACOLOGY, SPRINGERNATURE, pp. 61 - 62, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000725511400131&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2020, 'Alterations in the Kynurenine Pathway in Depression With and Without Psychosis', in BIOLOGICAL PSYCHIATRY, ELSEVIER SCIENCE INC, NY, New York, pp. S248 - S248, presented at
, 2020, 'Peripheral Inflammation Markers Identify a Subset of Patients With Schizophrenia and Related Psychoses who Display Intellectual Decline From Premorbid Levels', in BIOLOGICAL PSYCHIATRY, ELSEVIER SCIENCE INC, NY, New York, pp. S319 - S319, presented at
, 2020, 'ELEVATION OF MACROPHAGE-RELATED TRANSCRIPTS IN THE MIDBRAIN IN SCHIZOPHRENIA', in SCHIZOPHRENIA BULLETIN, OXFORD UNIV PRESS, ITALY, Florence, pp. S27 - S28, presented at
, 2020, 'INCREASED INFLAMMATION AND MACROPHAGE INFILTRATION IS ASSOCIATED WITH ALTERED SUBEPENDYMAL ZONE NEUROGENESIS IN SCHIZOPHRENIA BUT NOT BIPOLAR DISORDER', in SCHIZOPHRENIA BULLETIN, OXFORD UNIV PRESS, ITALY, Florence, pp. S28 - S29, presented at
, 2020, 'INVESTIGATING THE BEST PREDICTIVE CLINICAL FEATURES OF ANTI-N-METHYL-D-ASPARTATE RECEPTOR (NMDAR) ENCEPHALITIS IN THE 2010 AUSTRALIAN NATIONAL SURVEY OF HIGH IMPACT PSYCHOSIS (SHIP) COHORT', in SCHIZOPHRENIA BULLETIN, OXFORD UNIV PRESS, ITALY, Florence, pp. S172 - S173, presented at
, 2020, 'PERIPHERAL INFLAMMATION MARKERS IDENTIFY SUBSET OF PATIENTS WITH SCHIZOPHRENIA AND RELATED PSYCHOSES WHO HAVE INTELLECTUAL DECLINE FROM PREMORBID LEVELS', in SCHIZOPHRENIA BULLETIN, OXFORD UNIV PRESS, ITALY, Florence, pp. S158 - S158, presented at
, 2018, 'Reduction in Peripheral C-Reactive Protein Levels With Canakinumab Administration is Related to Reduced Positive Symptom Severity in Patients With Schizophrenia and Inflammation', in NEUROPSYCHOPHARMACOLOGY, NATURE PUBLISHING GROUP, pp. S176 - S177, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000509546600338&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2018, 'The Pharmacogenomics of Clozapine-Induced Myocarditis (PROCLAIM) Consortium', in NEUROPSYCHOPHARMACOLOGY, NATURE PUBLISHING GROUP, pp. S479 - S480, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000509546600873&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2017, 'C-Reactive Protein as a Marker of Inflammation in Acute Psychosis and Schizophrenia', in BIOLOGICAL PSYCHIATRY, ELSEVIER SCIENCE INC, CA, San Diego, pp. S312 - S313, presented at
, 2017, 'Efficacy of Transcranial Direct Current Stimulation in Unipolar and Bipolar Depression: Results from an International Randomized Controlled Trial', in BIOLOGICAL PSYCHIATRY, ELSEVIER SCIENCE INC, CA, San Diego, pp. S30 - S31, presented at
, 2017, 'Evidence for Blood-Brain Barrier Disruption and Antibody Presence in Brains of People with Schizophrenia', in BIOLOGICAL PSYCHIATRY, ELSEVIER SCIENCE INC, CA, San Diego, pp. S311 - S312, presented at
, 2017, 'Increased C3 and C4 Proteins in Serum of FEP and UHR Patients: Implications for Inflammatory Subtyping in SCZ', in BIOLOGICAL PSYCHIATRY, ELSEVIER SCIENCE INC, CA, San Diego, pp. S27 - S28, presented at
, 2016, 'Lower Brain pH as a Shared Endophenotype of Psychiatric Disorders', in NEUROPSYCHOPHARMACOLOGY, NATURE PUBLISHING GROUP, pp. S410 - S411, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000440365600687&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2016, 'An Investigation of Brain Structural Abnormalities in Neurocognitive Subgroups of Schizophrenia', in BIOLOGICAL PSYCHIATRY, ELSEVIER SCIENCE INC, pp. 392S - 392S, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000432440805108&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2016, 'Imbalance of Kynurenine Metabolism is Induced by Proinflammatory Cytokines and Associated with Working Memory and Dorsolateral Prefrontal Cortex Volume in Schizophrenia', in BIOLOGICAL PSYCHIATRY, ELSEVIER SCIENCE INC, pp. 392S - 392S, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000432440805109&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2015, 'Differential Effects of Disease Associated ST8SIA2 Haplotype on Cortical White Matter in Schizophrenia', in EUROPEAN NEUROPSYCHOPHARMACOLOGY, ELSEVIER SCIENCE BV, Toronto, Canada, pp. S237 - S238, presented at
, 2014, 'Adjunctive raloxifene treatment improves attention and memory in men and women with schizophrenia', in Molecular Psychiatry, Springer Nature, AZ, Phoenix, pp. 685 - 694, presented at
, 2014, 'Altered Subventricular Zone Niche in Schizophrenia Patients with Immune Activation', in NEUROPSYCHOPHARMACOLOGY, NATURE PUBLISHING GROUP, AZ, Phoenix, pp. S329 - S330, presented at
, 2014, 'Neuregulin-1 Loci Recently Associated with Psychosis Onset are Associated with Increased NRG1 mRNA and Lateral Ventricle Volume', in NEUROPSYCHOPHARMACOLOGY, NATURE PUBLISHING GROUP, AZ, Phoenix, pp. S410 - S411, presented at
, 2014, 'Adolescent cannabinoid exposure after maternal immune activation increases proliferation in the adult subventricular zone', in INTERNATIONAL JOURNAL OF DEVELOPMENTAL NEUROSCIENCE, PERGAMON-ELSEVIER SCIENCE LTD, CANADA, Montreal, pp. 67 - 67, presented at
, 2014, 'Levels of growth factors are altered in the hippocampus in Parkinson's disease', in MOVEMENT DISORDERS, WILEY-BLACKWELL, SWEDEN, Stockholm, pp. S35 - S35, presented at
Filter by type
https://orcid.org/0000-0002-4560-0259